Chapter 10 - Remission of Metabolic Syndrome After Sleeve Gastrectomy

Abstract

Impaired glucose tolerance, hypertension, and dyslipidemia have been described as metabolic syndrome (MS). MS is associated with an increased cardiovascular risk. A close association between morbid obesity and MS has been demonstrated. Bariatric surgery has been shown to be effective in achieving and maintaining weight change and reducing obesity-related comorbidities. Sleeve gastrectomy is a novel restrictive procedure, and evidence of its effect on MS is limited. Short- and mid-term data indicate that sleeve gastrectomy may improve type 2 diabetes mellitus, lipid profile, and hypertension.